Biogen agrees to pay $900 million in largest FCA Settlement Ever Secured without Government’s Intervention
FDA Law Blog
OCTOBER 3, 2022
district court of Massachusetts by former employee and whistleblower Michael Bawduniak in April 2012 as a qui tam action. Department of Health and Human Services (HHS) and the Department of Justice (DOJ) have aggressively pursued antikickback cases in the healthcare industry. Wasserstein — On September 26, 2022, Biogen Inc.
105 
Let's personalize your content